Stock 4161 BIOPTIK TECHNOLOGY INCORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Bioptik Technology Incorporation

Equities

4161

TW0004161005

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
34.25 TWD 0.00% Intraday chart for Bioptik Technology Incorporation +0.59% +6.53%
Mar. 13 Bioptik Technology Incorporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Bioptik Technology Incorporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,577 1,651 1,277 1,347 1,361 1,703
Enterprise Value (EV) 1 1,652 1,797 1,478 1,632 1,637 1,778
P/E ratio 61.1 x 314 x -21.3 x 59.6 x 28.2 x 19.3 x
Yield 1.55% 1.75% 1.13% 1.08% - -
Capitalization / Revenue 3.04 x 2.91 x 2.63 x 1.83 x 1.77 x 2.06 x
EV / Revenue 3.18 x 3.17 x 3.04 x 2.21 x 2.13 x 2.15 x
EV / EBITDA 46.5 x 51.3 x -156 x 24.2 x 24.2 x 14.8 x
EV / FCF -31.7 x -753 x 207 x -22.6 x 650 x 13.3 x
FCF Yield -3.15% -0.13% 0.48% -4.42% 0.15% 7.51%
Price to Book 1.94 x 2.16 x 1.75 x 1.95 x 1.9 x 2.08 x
Nbr of stocks (in thousands) 51,281 50,685 50,685 50,685 50,685 52,981
Reference price 2 30.76 32.57 25.19 26.57 26.86 32.15
Announcement Date 4/1/19 3/31/20 3/24/21 3/18/22 3/20/23 3/13/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 519.6 566.4 485.6 737.9 767.8 828.5
EBITDA 1 35.5 35.01 -9.442 67.29 67.73 119.7
EBIT 1 2.153 -1.472 -42.23 35.73 39.48 89.95
Operating Margin 0.41% -0.26% -8.7% 4.84% 5.14% 10.86%
Earnings before Tax (EBT) 1 31.49 -0.305 -63.69 19.62 62.81 106.5
Net income 1 26.39 5.251 -59.99 22.59 48.5 85.71
Net margin 5.08% 0.93% -12.35% 3.06% 6.32% 10.35%
EPS 2 0.5036 0.1036 -1.184 0.4457 0.9524 1.670
Free Cash Flow 1 -52.11 -2.388 7.132 -72.18 2.52 133.4
FCF margin -10.03% -0.42% 1.47% -9.78% 0.33% 16.1%
FCF Conversion (EBITDA) - - - - 3.72% 111.44%
FCF Conversion (Net income) - - - - 5.2% 155.68%
Dividend per Share 2 0.4762 0.5714 0.2857 0.2857 - -
Announcement Date 4/1/19 3/31/20 3/24/21 3/18/22 3/20/23 3/13/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 74.8 147 201 285 276 74.3
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.106 x 4.188 x -21.26 x 4.236 x 4.069 x 0.6204 x
Free Cash Flow 1 -52.1 -2.39 7.13 -72.2 2.52 133
ROE (net income / shareholders' equity) 2.68% 0% -8.27% 2.87% 6.66% 11%
ROA (Net income/ Total Assets) 0.08% -0.06% -1.74% 1.49% 1.62% 3.73%
Assets 1 31,081 -9,022 3,441 1,517 2,987 2,297
Book Value Per Share 2 15.90 15.00 14.40 13.60 14.10 15.50
Cash Flow per Share 2 5.100 8.770 5.090 2.050 6.130 6.960
Capex 1 51 27.4 13 19.1 16.9 30.4
Capex / Sales 9.81% 4.84% 2.68% 2.59% 2.2% 3.67%
Announcement Date 4/1/19 3/31/20 3/24/21 3/18/22 3/20/23 3/13/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
BIOPTIK TECHNOLOGY INCORPORATION Stock Bioptik Technology Incorporation
+6.53% 55.63M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 4161 Stock
  4. Financials Bioptik Technology Incorporation